Publications

LSHTM

Found 0 results for your search. Showing 0 to 0.

No results could be found for your search.

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Patient and public involvement within epidemiological studies of long COVID in the UK.

Routen, A; O'Mahoney, L; Aiyegbusi, OL; Alder, Y; Banerjee, A; Buckland, L; Brightling, C; Calvert, M; Camaradou, J; Chaturvedi, N; Chong, A; Dalrymple, E; EGGO, RM; Elliott, P; Evans, RA; Gibson, A; Haroon, S; HERRETT, E; Houchen-Wolloff, L; Hughes, SE; Jeyes, F; Matthews, K; McMullan, C; Morley, J; Shafran, R; ... Khunti, K.

2023

Nature medicine, (2023).29 4 10.1038/s41591-023-02251-5.

First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY.

Hopcroft, LE; Curtis, HJ; Brown, AD; Hulme, WJ; Andrews, CD; Morton, CE; Inglesby, P; Morley, J; Mehrkar, A; Bacon, SC; EGGO, RM; Mahalingasivam, V; Parker, EP K; TOMLINSON, LA; Bates, C; Cockburn, J; Parry, J; Hester, F; Harper, S; Goldacre, B; Walker, AJ; MacKenna, B;

2023

Wellcome Open Research, (2023).8, 10.12688/wellcomeopenres.18735.1.

Excess Mortality Among Patients in the Veterans Affairs Health System Compared With the Overall US Population During the First Year of the COVID-19 Pandemic.

Weinberger, DM; Rose, L; RENTSCH, C; Asch, SM; Columbo, JA; King, J; Korves, C; Lucas, BP; Taub, C; Young-Xu, Y; Vashi, A; Davies, L; Justice, AC;

2023

JAMA Network Open, (2023).6 5 10.1001/jamanetworkopen.2023.12140.

Previous BCG vaccination is associated with less severe clinical progression of COVID-19.

Pereira, SM; Barreto, FR; De Souza, RA; De Souza Teles Santos, CA; Pereira, M; Da Paixão, ES; De Jesus Lima, CC O; Da Natividade, MS; Lindoso, AA B P; Fernandes, EG; Junior, EB C; PESCARINI, JM; De Andrade, KV F; De Souza, FM; De Britto, EA; Nunes, C; Ichihara, MY; Dalcolmo, M; Trajman, A; Barral-Netto, M; Abubakar, I; Barreto, ML; De Alencar Ximenes, RA; RODRIGUES, LC;

2023

BMC medicine, (2023).21 1 10.1186/s12916-023-02859-x.

One year of digital contact tracing: Who was more likely to install the NHS COVID-19 app? Results from a tracker survey in England and Wales.

AL-HABOUBI, M; EXLEY, J; ALLEL, K; Erens, B; MAYS, N;

2023

Digital Health, (2023).9, 10.1177/20552076231159449.

Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients: observational cohort study using the OpenSAFELY platform.

Zheng, B; Tazare, J; Nab, L; Mehrkar, A; MacKenna, B; GOLDACRE, B; Douglas, I; TOMLINSON, L;

2023

medRxiv (2023). 10.1101/2023.01.20.23284849.

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months.

SERWANGA, J; Ankunda, V; Sembera, J; Kato, L; Oluka, GK; Baine, C; Odoch, G; Kayiwa, J; Auma, BO; Jjuuko, M; Nsereko, C; Cotten, M; Onyachi, N; Muwanga, M; Lutalo, T; Fox, J; Musenero, M; KALEEBU, P; COVID-19 Immunoprofiling Team,;

2023

Frontiers in immunology, (2023).14, 10.3389/fimmu.2023.1152522.

A network of empirical ethics teams embedded in research programmes across multiple sites: opportunities and challenges in contributing to COVID-19 research and responses.

Ngwenya, N; Ilo Van Nuil, J; Nyirenda, D; Chambers, M; Cheah, PY; SEELEY, J; Chi, P; Mafuleka, L; Nkosi, B; Kamuya, D; Davies, A; Schneiders, ML; Mumba, N; Dlamini, S; DESMOND, N; Marsh, V; Rippon, D; Parker, M; Molyneux, S;

2023

Wellcome open research, (2023).7, 10.12688/wellcomeopenres.17548.2.

Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study.

Pinto-Filho, MM; Paixão, GM; Gomes, PR; Soares, CP M; Singh, K; Rossi, VA; Thienemann, F; Viljoen, C; Mohan, B; Sarrafzadegan, N; Chowdhury, AW; Ntusi, N; Deora, S; PEREL, P; Prabhakaran, D; Sliwa, K; Ribeiro, AL P;

2023

Heart (British Cardiac Society), (2023).109 9 10.1136/heartjnl-2022-321754.

Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial.

Llanos-Cuentas, A; SCHWALB, A; Quintana, JL; Delfin, B; Alvarez, F; Ugarte-Gil, C; Guerra Gronerth, RI; Lucchetti, A; Grogl, M; Gotuzzo, E;

2023

BMC research notes, (2023).16 1 10.1186/s13104-023-06281-7.